Stock analysts at Deutsche Bank initiated coverage on shares of Cardinal Health (NYSE:CAH) in a note issued to investors on Monday, MarketBeat reports. The brokerage set a “hold” rating and a $64.00 price target on the stock. Deutsche Bank’s target price would indicate a potential upside of 4.88% from the company’s previous close.

CAH has been the subject of a number of other reports. Morgan Stanley lowered Cardinal Health from an “equal weight” rating to an “underweight” rating in a research report on Monday, November 20th. Argus lowered Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research report on Thursday, October 12th. Finally, Royal Bank Of Canada started coverage on Cardinal Health in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $72.00 target price for the company. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $73.91.

Cardinal Health (NYSE CAH) traded up $2.12 during trading on Monday, hitting $61.02. The company had a trading volume of 6,033,358 shares, compared to its average volume of 2,442,061. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52. Cardinal Health has a fifty-two week low of $54.66 and a fifty-two week high of $84.88. The company has a market capitalization of $18,530.15, a PE ratio of 11.18, a price-to-earnings-growth ratio of 1.70 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.09. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The company’s revenue was up 1.9% on a year-over-year basis. During the same period last year, the company earned $1.24 earnings per share. equities analysts predict that Cardinal Health will post 4.97 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in shares of Cardinal Health by 1.9% during the 2nd quarter. Vanguard Group Inc. now owns 23,642,277 shares of the company’s stock worth $1,842,205,000 after purchasing an additional 440,967 shares in the last quarter. BlackRock Inc. raised its stake in shares of Cardinal Health by 6.5% during the 2nd quarter. BlackRock Inc. now owns 22,843,418 shares of the company’s stock worth $1,779,958,000 after purchasing an additional 1,398,496 shares in the last quarter. Macquarie Group Ltd. raised its stake in shares of Cardinal Health by 4.6% during the 3rd quarter. Macquarie Group Ltd. now owns 10,105,374 shares of the company’s stock worth $676,253,000 after purchasing an additional 445,399 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Cardinal Health by 72.1% during the 2nd quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock worth $489,613,000 after purchasing an additional 2,632,836 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of Cardinal Health by 38.6% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,930,457 shares of the company’s stock worth $329,964,000 after purchasing an additional 1,373,334 shares in the last quarter. Hedge funds and other institutional investors own 88.47% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/04/cardinal-health-cah-coverage-initiated-at-deutsche-bank.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.